期刊文献+

OSAHS患者外周血肿瘤坏死因子-α mRNA表达及其蛋白水平的变化和意义

The Changes of mRNA Expression and Serum Levels of Tumor Necrosis Factor-A in the Peripheral Blood of Patients with Obstructive Sleep Apnea-Hypopnea Syndrome
下载PDF
导出
摘要 目的探讨肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)在阻塞性睡眠呼吸暂停-低通气综合征(obstructive sleep apnea-hypopnea syndrome,OS"HS)患者中的作用和临床意义。方法分别用RT-PCR方法分析患者组和对照组外周血单个核细胞(peripheral blood mononuclear cells,PBMCs)中TNF-α基因的表达及化学发光法检测血清中TNF-α水平。结果OS"HS组与对照组相比,中重度OSAHS患者组TNF-α mRNA表达较正常对照组高[(42.75±20.00)%vs(28.16±12.49)%](P<0.05),轻度组与中重度组及正常对照组比较差异无统计学意义(P>0.05);各组间血清TNF-α水平差异无统计学意义(P>0.05),但血清TNF-α水平与呼吸暂停低通气指数(apnea-hypopnea index,AHI)及氧减指数呈正相关(r分别为0.456、0.552,P均<0.05),与夜间最低血氧饱和度呈负相关(r=-0.452,P<0.05)。结论炎症因子TNF-α可能参与OSAHS的病理生理过程。 Objective To investigate the role and clinical significance of tumor necrosis factor-or (TNF-α) in patients with obstructive sleep apnea-hypopnea syndrome (OSAHS). Method Expression of TNF-α mRNA in PBMCs was determined by RT-PCR and the level of serum TNF-α was measured by chemiluminescence. Result The expression of TNF-α mRNA in moderate to severe OSAHS patients (42.75±20) % was higher than the control subjects (28.16±12.49)%, P〈0.05. The level of serum TNF-α in OSAHS patients was not significantly different from the control subjects (P 〉0.05). However, the level of serum TNF-α was positively correlated with AHI (r=0.456, P〈 0.05) and oxidative desaturation index (ODI,r=0.552, P〈0.05), and negatively correlated with the minimal SPO2 (r=-0.452,P〈0.05). Conclusion The level of pro-inflammatory cytokine TNF-α may be involved in the pathogenic development of cardiovascular diseases in patients with OSAHS.
出处 《热带医学杂志》 CAS 2008年第8期772-774,共3页 Journal of Tropical Medicine
基金 广东省科技计划项目(No.2005B30601015) 广州市科技计划项目(No.2005Z2-E0081)
关键词 阻塞性睡眠呼吸暂停低通气综合征 肿瘤坏死因子-Α 炎症反应 obstructive sleep apnea-hypopnea syndrome tumor necrosis factor-or inflammatory reaction
  • 相关文献

参考文献9

  • 1王士雯,张文莉.睡眠呼吸障碍与心血管疾病[J].现代实用医学,2003,15(4):205-207. 被引量:8
  • 2Hedner J, Bengtsson-Bostro¨m K, Peker Y, et al. Hypertension prevalence in obstructive sleep apnoea and sex: a population- based ease-control study [ J ]. Eur Respir J, 2006,27 ( 3 ) : 564- 570.
  • 3American Academy of Sleep Medicine Task Force. Sleep related breathing disorders in adults : recommendations for syndrome definition and measurement techniques in clinical research [ J ], Sleep, 1999,22 (5) : 667-689.
  • 4Yokoe T, Minoguehi K, Matsuo H,et al. Elevated levels of C- reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure [J ]. Circulation, 2003,107( 8 ) : 1129-1134.
  • 5Minoguchi K,Tazaki T,Yokoe T,et al. Elevated production of tumor necrosis factor-alpha by monocytes in patientswith obstructive sleep apnea syndrome [ J ]. Chest, 2004, 126 ( 5 ) : 1473-1479.
  • 6Kokturk O, Ciftci TU, Mollarecep E, et al. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome [J]. Int Heart J,2005, 46 ( 5 ) : 801-809.
  • 7Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome [ J ]. Circulation, 2005,112 ( 17 ) : 2660- 2667.
  • 8Marin JM, Carrizo S J, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure:an observational study [J]. Lancet,2005,365 (9464) :1046- 1053.
  • 9Doherty LS, Kiely JL, Swan V, et al. Longterm effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome [J]. Chest, 2005,127 (6) : 2076-2084.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部